FDA Inspection 779650 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 2377733

The FDA completed an inspection of Octapharma Plasma, Inc. on Apr 9, 2012 in Gretna, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 9, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Gretna, LA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.